Skip to main content
Equibles

MARSHALL WACE, LLP

Position in CRDF — Cardiff Oncology, Inc.

CIK 1318757 LONDON, X0
Back to CRDF Full portfolio

Position in CRDF

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$210,877
-$730,075 QoQ
Shares Held
162,214
-45.7% QoQ
Ownership
0.209%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 104 holders
Holding Since
Jun 2021
10 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in CRDF Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $3,055,517,440 across 267 Biotechnology names. CRDF ranks #246 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 543,897 $270,169,956
2 INCY
Incyte Corp
 1,310,154 $148,519,056
3 RPRX
Royalty Pharma plc
 2,450,669 $137,409,009
4 SYRE
Spyre Therapeutics, Inc.
 991,693 $88,042,503
5 ALNY
Alnylam Pharmaceuticals, Inc.
 259,799 $78,207,292
6 TVTX
Travere Therapeutics, Inc.
 1,333,207 $75,739,488
7 MANE
Veradermics, Inc
 585,560 $71,988,746
8 DFTX
Definium Therapeutics, Inc.
 1,298,946 $61,102,419

All Filings in CRDF

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $210,877 162,214
2025-06-30 $940,952 298,715
2025-03-31 $1,269,533 404,310
2024-12-31 $271,684 62,600
2024-09-30 $381,879 143,026
2024-06-30 $663,400 298,829
2024-03-31 $2,320,667 434,582
2021-12-31 $401,924 66,876
2021-09-30 $125,001 18,769
2021-06-30 $1,695,277 254,929